Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of Sitagliptin in Chinese T2DM Patients
NCT03108521Phase 4Completed
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Apr 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Glycosylated Hemoglobin A1c at 12 weeks. Started Apr 2016; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03108521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03108521.